CLIN CHEM 润色咨询

CLINICAL CHEMISTRY

出版年份：1955 年文章数：2805 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：5.8% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1088804, encodeId=a7541088804c8, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088803, encodeId=e222108880356, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861495, encodeId=984f861495b8, content=审稿速度:1.0<br>经验分享：投的是一个letter to editor。从投稿到接收用时3周，期间状态为paper out for review. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Fri Jun 05 23:03:32 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544353, encodeId=397b544353a6, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=611, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833235, encodeId=acb5833235e1, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：不知道做质谱分析的，可潜在应用于临床方面，能不能再这上面发文？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Fri Aug 19 15:14:24 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500575, encodeId=4fb75005e5ce, content=请问： <br> 我最近投了一篇Clinical Chemistry, 现在的状态是 needs second opinion, 而且还换了一个editor? <br> 请问哪位遇到过这种情况？会是凶多吉少？ <br> <br> 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=580, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 09 22:26:00 CST 2014, time=2014-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498074, encodeId=90fc4980e4e4, content=此杂志审稿过程确实较慢，我2013年4月23日投稿，5月10号一审结束，需要追加实验，5月27日追加实验后再投，之后就是漫长的等待，居然一直到7月24日才接收，是个漫长的过程，我的追加实验过程还是快的，不然耗时更长，如果着急毕业的，投此杂志需要慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=624, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xie, createdTime=Thu Jul 25 10:05:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495068, encodeId=5b5349506851, content=有很多类别，我投的是分子诊断的，所以偏基础研究<span class="quote">临床和基础文章那一个容易些?<span class="quote">好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇</span></span>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=598, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d4a78078, createdName=zzxxzz, createdTime=Tue Apr 16 02:04:00 CST 2013, time=2013-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494987, encodeId=c5fb49498e8c, content=临床和基础文章那一个容易些?<span class="quote">好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇</span>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=621, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Apr 11 16:04:00 CST 2013, time=2013-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494101, encodeId=fcda494101b0, content=好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=641, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Feb 27 23:03:00 CST 2013, time=2013-02-27, status=1, ipAttribution=)]
    2021-12-29 桑晒麦拉

    选择期刊时应该注意什么？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1088804, encodeId=a7541088804c8, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088803, encodeId=e222108880356, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861495, encodeId=984f861495b8, content=审稿速度:1.0<br>经验分享：投的是一个letter to editor。从投稿到接收用时3周，期间状态为paper out for review. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Fri Jun 05 23:03:32 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544353, encodeId=397b544353a6, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=611, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833235, encodeId=acb5833235e1, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：不知道做质谱分析的，可潜在应用于临床方面，能不能再这上面发文？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Fri Aug 19 15:14:24 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500575, encodeId=4fb75005e5ce, content=请问： <br> 我最近投了一篇Clinical Chemistry, 现在的状态是 needs second opinion, 而且还换了一个editor? <br> 请问哪位遇到过这种情况？会是凶多吉少？ <br> <br> 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=580, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 09 22:26:00 CST 2014, time=2014-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498074, encodeId=90fc4980e4e4, content=此杂志审稿过程确实较慢，我2013年4月23日投稿，5月10号一审结束，需要追加实验，5月27日追加实验后再投，之后就是漫长的等待，居然一直到7月24日才接收，是个漫长的过程，我的追加实验过程还是快的，不然耗时更长，如果着急毕业的，投此杂志需要慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=624, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xie, createdTime=Thu Jul 25 10:05:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495068, encodeId=5b5349506851, content=有很多类别，我投的是分子诊断的，所以偏基础研究<span class="quote">临床和基础文章那一个容易些?<span class="quote">好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇</span></span>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=598, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d4a78078, createdName=zzxxzz, createdTime=Tue Apr 16 02:04:00 CST 2013, time=2013-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494987, encodeId=c5fb49498e8c, content=临床和基础文章那一个容易些?<span class="quote">好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇</span>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=621, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Apr 11 16:04:00 CST 2013, time=2013-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494101, encodeId=fcda494101b0, content=好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=641, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Feb 27 23:03:00 CST 2013, time=2013-02-27, status=1, ipAttribution=)]
    2021-12-27 乌云背后的幸福线

    选刊的流程是什么？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1088804, encodeId=a7541088804c8, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088803, encodeId=e222108880356, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861495, encodeId=984f861495b8, content=审稿速度:1.0<br>经验分享：投的是一个letter to editor。从投稿到接收用时3周，期间状态为paper out for review. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Fri Jun 05 23:03:32 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544353, encodeId=397b544353a6, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=611, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833235, encodeId=acb5833235e1, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：不知道做质谱分析的，可潜在应用于临床方面，能不能再这上面发文？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Fri Aug 19 15:14:24 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500575, encodeId=4fb75005e5ce, content=请问： <br> 我最近投了一篇Clinical Chemistry, 现在的状态是 needs second opinion, 而且还换了一个editor? <br> 请问哪位遇到过这种情况？会是凶多吉少？ <br> <br> 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=580, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 09 22:26:00 CST 2014, time=2014-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498074, encodeId=90fc4980e4e4, content=此杂志审稿过程确实较慢，我2013年4月23日投稿，5月10号一审结束，需要追加实验，5月27日追加实验后再投，之后就是漫长的等待，居然一直到7月24日才接收，是个漫长的过程，我的追加实验过程还是快的，不然耗时更长，如果着急毕业的，投此杂志需要慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=624, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xie, createdTime=Thu Jul 25 10:05:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495068, encodeId=5b5349506851, content=有很多类别，我投的是分子诊断的，所以偏基础研究<span class="quote">临床和基础文章那一个容易些?<span class="quote">好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇</span></span>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=598, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d4a78078, createdName=zzxxzz, createdTime=Tue Apr 16 02:04:00 CST 2013, time=2013-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494987, encodeId=c5fb49498e8c, content=临床和基础文章那一个容易些?<span class="quote">好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇</span>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=621, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Apr 11 16:04:00 CST 2013, time=2013-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494101, encodeId=fcda494101b0, content=好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=641, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Feb 27 23:03:00 CST 2013, time=2013-02-27, status=1, ipAttribution=)]
    2020-06-05 ms5054295132918558

    审稿速度:1.0
    经验分享：投的是一个letter to editor。从投稿到接收用时3周，期间状态为paper out for review.

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1088804, encodeId=a7541088804c8, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088803, encodeId=e222108880356, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861495, encodeId=984f861495b8, content=审稿速度:1.0<br>经验分享：投的是一个letter to editor。从投稿到接收用时3周，期间状态为paper out for review. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Fri Jun 05 23:03:32 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544353, encodeId=397b544353a6, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=611, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833235, encodeId=acb5833235e1, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：不知道做质谱分析的，可潜在应用于临床方面，能不能再这上面发文？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Fri Aug 19 15:14:24 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500575, encodeId=4fb75005e5ce, content=请问： <br> 我最近投了一篇Clinical Chemistry, 现在的状态是 needs second opinion, 而且还换了一个editor? <br> 请问哪位遇到过这种情况？会是凶多吉少？ <br> <br> 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=580, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 09 22:26:00 CST 2014, time=2014-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498074, encodeId=90fc4980e4e4, content=此杂志审稿过程确实较慢，我2013年4月23日投稿，5月10号一审结束，需要追加实验，5月27日追加实验后再投，之后就是漫长的等待，居然一直到7月24日才接收，是个漫长的过程，我的追加实验过程还是快的，不然耗时更长，如果着急毕业的，投此杂志需要慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=624, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xie, createdTime=Thu Jul 25 10:05:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495068, encodeId=5b5349506851, content=有很多类别，我投的是分子诊断的，所以偏基础研究<span class="quote">临床和基础文章那一个容易些?<span class="quote">好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇</span></span>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=598, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d4a78078, createdName=zzxxzz, createdTime=Tue Apr 16 02:04:00 CST 2013, time=2013-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494987, encodeId=c5fb49498e8c, content=临床和基础文章那一个容易些?<span class="quote">好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇</span>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=621, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Apr 11 16:04:00 CST 2013, time=2013-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494101, encodeId=fcda494101b0, content=好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=641, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Feb 27 23:03:00 CST 2013, time=2013-02-27, status=1, ipAttribution=)]
    2017-07-16 13305510181

    涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1088804, encodeId=a7541088804c8, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088803, encodeId=e222108880356, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861495, encodeId=984f861495b8, content=审稿速度:1.0<br>经验分享：投的是一个letter to editor。从投稿到接收用时3周，期间状态为paper out for review. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Fri Jun 05 23:03:32 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544353, encodeId=397b544353a6, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=611, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833235, encodeId=acb5833235e1, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：不知道做质谱分析的，可潜在应用于临床方面，能不能再这上面发文？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Fri Aug 19 15:14:24 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500575, encodeId=4fb75005e5ce, content=请问： <br> 我最近投了一篇Clinical Chemistry, 现在的状态是 needs second opinion, 而且还换了一个editor? <br> 请问哪位遇到过这种情况？会是凶多吉少？ <br> <br> 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=580, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 09 22:26:00 CST 2014, time=2014-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498074, encodeId=90fc4980e4e4, content=此杂志审稿过程确实较慢，我2013年4月23日投稿，5月10号一审结束，需要追加实验，5月27日追加实验后再投，之后就是漫长的等待，居然一直到7月24日才接收，是个漫长的过程，我的追加实验过程还是快的，不然耗时更长，如果着急毕业的，投此杂志需要慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=624, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xie, createdTime=Thu Jul 25 10:05:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495068, encodeId=5b5349506851, content=有很多类别，我投的是分子诊断的，所以偏基础研究<span class="quote">临床和基础文章那一个容易些?<span class="quote">好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇</span></span>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=598, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d4a78078, createdName=zzxxzz, createdTime=Tue Apr 16 02:04:00 CST 2013, time=2013-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494987, encodeId=c5fb49498e8c, content=临床和基础文章那一个容易些?<span class="quote">好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇</span>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=621, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Apr 11 16:04:00 CST 2013, time=2013-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494101, encodeId=fcda494101b0, content=好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=641, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Feb 27 23:03:00 CST 2013, time=2013-02-27, status=1, ipAttribution=)]
    2016-08-19 ms6967342940128728

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享：不知道做质谱分析的，可潜在应用于临床方面，能不能再这上面发文？

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1088804, encodeId=a7541088804c8, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088803, encodeId=e222108880356, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861495, encodeId=984f861495b8, content=审稿速度:1.0<br>经验分享：投的是一个letter to editor。从投稿到接收用时3周，期间状态为paper out for review. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Fri Jun 05 23:03:32 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544353, encodeId=397b544353a6, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=611, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833235, encodeId=acb5833235e1, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：不知道做质谱分析的，可潜在应用于临床方面，能不能再这上面发文？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Fri Aug 19 15:14:24 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500575, encodeId=4fb75005e5ce, content=请问： <br> 我最近投了一篇Clinical Chemistry, 现在的状态是 needs second opinion, 而且还换了一个editor? <br> 请问哪位遇到过这种情况？会是凶多吉少？ <br> <br> 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=580, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 09 22:26:00 CST 2014, time=2014-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498074, encodeId=90fc4980e4e4, content=此杂志审稿过程确实较慢，我2013年4月23日投稿，5月10号一审结束，需要追加实验，5月27日追加实验后再投，之后就是漫长的等待，居然一直到7月24日才接收，是个漫长的过程，我的追加实验过程还是快的，不然耗时更长，如果着急毕业的，投此杂志需要慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=624, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xie, createdTime=Thu Jul 25 10:05:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495068, encodeId=5b5349506851, content=有很多类别，我投的是分子诊断的，所以偏基础研究<span class="quote">临床和基础文章那一个容易些?<span class="quote">好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇</span></span>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=598, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d4a78078, createdName=zzxxzz, createdTime=Tue Apr 16 02:04:00 CST 2013, time=2013-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494987, encodeId=c5fb49498e8c, content=临床和基础文章那一个容易些?<span class="quote">好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇</span>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=621, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Apr 11 16:04:00 CST 2013, time=2013-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494101, encodeId=fcda494101b0, content=好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=641, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Feb 27 23:03:00 CST 2013, time=2013-02-27, status=1, ipAttribution=)]
    2014-01-09 匿名用户

    请问：
    我最近投了一篇Clinical Chemistry, 现在的状态是 needs second opinion, 而且还换了一个editor?
    请问哪位遇到过这种情况？会是凶多吉少？

    谢谢！

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1088804, encodeId=a7541088804c8, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088803, encodeId=e222108880356, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861495, encodeId=984f861495b8, content=审稿速度:1.0<br>经验分享：投的是一个letter to editor。从投稿到接收用时3周，期间状态为paper out for review. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Fri Jun 05 23:03:32 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544353, encodeId=397b544353a6, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=611, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833235, encodeId=acb5833235e1, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：不知道做质谱分析的，可潜在应用于临床方面，能不能再这上面发文？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Fri Aug 19 15:14:24 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500575, encodeId=4fb75005e5ce, content=请问： <br> 我最近投了一篇Clinical Chemistry, 现在的状态是 needs second opinion, 而且还换了一个editor? <br> 请问哪位遇到过这种情况？会是凶多吉少？ <br> <br> 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=580, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 09 22:26:00 CST 2014, time=2014-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498074, encodeId=90fc4980e4e4, content=此杂志审稿过程确实较慢，我2013年4月23日投稿，5月10号一审结束，需要追加实验，5月27日追加实验后再投，之后就是漫长的等待，居然一直到7月24日才接收，是个漫长的过程，我的追加实验过程还是快的，不然耗时更长，如果着急毕业的，投此杂志需要慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=624, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xie, createdTime=Thu Jul 25 10:05:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495068, encodeId=5b5349506851, content=有很多类别，我投的是分子诊断的，所以偏基础研究<span class="quote">临床和基础文章那一个容易些?<span class="quote">好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇</span></span>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=598, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d4a78078, createdName=zzxxzz, createdTime=Tue Apr 16 02:04:00 CST 2013, time=2013-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494987, encodeId=c5fb49498e8c, content=临床和基础文章那一个容易些?<span class="quote">好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇</span>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=621, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Apr 11 16:04:00 CST 2013, time=2013-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494101, encodeId=fcda494101b0, content=好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=641, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Feb 27 23:03:00 CST 2013, time=2013-02-27, status=1, ipAttribution=)]
    2013-07-25 xie

    此杂志审稿过程确实较慢，我2013年4月23日投稿，5月10号一审结束，需要追加实验，5月27日追加实验后再投，之后就是漫长的等待，居然一直到7月24日才接收，是个漫长的过程，我的追加实验过程还是快的，不然耗时更长，如果着急毕业的，投此杂志需要慎重。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1088804, encodeId=a7541088804c8, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088803, encodeId=e222108880356, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861495, encodeId=984f861495b8, content=审稿速度:1.0<br>经验分享：投的是一个letter to editor。从投稿到接收用时3周，期间状态为paper out for review. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Fri Jun 05 23:03:32 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544353, encodeId=397b544353a6, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=611, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833235, encodeId=acb5833235e1, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：不知道做质谱分析的，可潜在应用于临床方面，能不能再这上面发文？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Fri Aug 19 15:14:24 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500575, encodeId=4fb75005e5ce, content=请问： <br> 我最近投了一篇Clinical Chemistry, 现在的状态是 needs second opinion, 而且还换了一个editor? <br> 请问哪位遇到过这种情况？会是凶多吉少？ <br> <br> 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=580, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 09 22:26:00 CST 2014, time=2014-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498074, encodeId=90fc4980e4e4, content=此杂志审稿过程确实较慢，我2013年4月23日投稿，5月10号一审结束，需要追加实验，5月27日追加实验后再投，之后就是漫长的等待，居然一直到7月24日才接收，是个漫长的过程，我的追加实验过程还是快的，不然耗时更长，如果着急毕业的，投此杂志需要慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=624, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xie, createdTime=Thu Jul 25 10:05:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495068, encodeId=5b5349506851, content=有很多类别，我投的是分子诊断的，所以偏基础研究<span class="quote">临床和基础文章那一个容易些?<span class="quote">好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇</span></span>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=598, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d4a78078, createdName=zzxxzz, createdTime=Tue Apr 16 02:04:00 CST 2013, time=2013-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494987, encodeId=c5fb49498e8c, content=临床和基础文章那一个容易些?<span class="quote">好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇</span>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=621, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Apr 11 16:04:00 CST 2013, time=2013-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494101, encodeId=fcda494101b0, content=好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=641, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Feb 27 23:03:00 CST 2013, time=2013-02-27, status=1, ipAttribution=)]
    2013-04-16 zzxxzz

    有很多类别，我投的是分子诊断的，所以偏基础研究临床和基础文章那一个容易些?好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1088804, encodeId=a7541088804c8, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088803, encodeId=e222108880356, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861495, encodeId=984f861495b8, content=审稿速度:1.0<br>经验分享：投的是一个letter to editor。从投稿到接收用时3周，期间状态为paper out for review. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Fri Jun 05 23:03:32 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544353, encodeId=397b544353a6, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=611, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833235, encodeId=acb5833235e1, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：不知道做质谱分析的，可潜在应用于临床方面，能不能再这上面发文？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Fri Aug 19 15:14:24 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500575, encodeId=4fb75005e5ce, content=请问： <br> 我最近投了一篇Clinical Chemistry, 现在的状态是 needs second opinion, 而且还换了一个editor? <br> 请问哪位遇到过这种情况？会是凶多吉少？ <br> <br> 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=580, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 09 22:26:00 CST 2014, time=2014-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498074, encodeId=90fc4980e4e4, content=此杂志审稿过程确实较慢，我2013年4月23日投稿，5月10号一审结束，需要追加实验，5月27日追加实验后再投，之后就是漫长的等待，居然一直到7月24日才接收，是个漫长的过程，我的追加实验过程还是快的，不然耗时更长，如果着急毕业的，投此杂志需要慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=624, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xie, createdTime=Thu Jul 25 10:05:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495068, encodeId=5b5349506851, content=有很多类别，我投的是分子诊断的，所以偏基础研究<span class="quote">临床和基础文章那一个容易些?<span class="quote">好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇</span></span>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=598, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d4a78078, createdName=zzxxzz, createdTime=Tue Apr 16 02:04:00 CST 2013, time=2013-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494987, encodeId=c5fb49498e8c, content=临床和基础文章那一个容易些?<span class="quote">好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇</span>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=621, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Apr 11 16:04:00 CST 2013, time=2013-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494101, encodeId=fcda494101b0, content=好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=641, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Feb 27 23:03:00 CST 2013, time=2013-02-27, status=1, ipAttribution=)]
    2013-04-11 匿名用户

    临床和基础文章那一个容易些?好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1088804, encodeId=a7541088804c8, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088803, encodeId=e222108880356, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861495, encodeId=984f861495b8, content=审稿速度:1.0<br>经验分享：投的是一个letter to editor。从投稿到接收用时3周，期间状态为paper out for review. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Fri Jun 05 23:03:32 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544353, encodeId=397b544353a6, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=611, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833235, encodeId=acb5833235e1, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：不知道做质谱分析的，可潜在应用于临床方面，能不能再这上面发文？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Fri Aug 19 15:14:24 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500575, encodeId=4fb75005e5ce, content=请问： <br> 我最近投了一篇Clinical Chemistry, 现在的状态是 needs second opinion, 而且还换了一个editor? <br> 请问哪位遇到过这种情况？会是凶多吉少？ <br> <br> 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=580, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 09 22:26:00 CST 2014, time=2014-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498074, encodeId=90fc4980e4e4, content=此杂志审稿过程确实较慢，我2013年4月23日投稿，5月10号一审结束，需要追加实验，5月27日追加实验后再投，之后就是漫长的等待，居然一直到7月24日才接收，是个漫长的过程，我的追加实验过程还是快的，不然耗时更长，如果着急毕业的，投此杂志需要慎重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=624, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xie, createdTime=Thu Jul 25 10:05:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495068, encodeId=5b5349506851, content=有很多类别，我投的是分子诊断的，所以偏基础研究<span class="quote">临床和基础文章那一个容易些?<span class="quote">好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇</span></span>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=598, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d4a78078, createdName=zzxxzz, createdTime=Tue Apr 16 02:04:00 CST 2013, time=2013-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494987, encodeId=c5fb49498e8c, content=临床和基础文章那一个容易些?<span class="quote">好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇</span>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=621, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Apr 11 16:04:00 CST 2013, time=2013-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494101, encodeId=fcda494101b0, content=好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=641, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Feb 27 23:03:00 CST 2013, time=2013-02-27, status=1, ipAttribution=)]
    2013-02-27 匿名用户

    好杂志，if不高但属于一区的。审稿时间4-6周，目前投了两篇，接收一篇

    0

共15条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分